FINANCIAL HIGHLIGHTS

We delivered outstanding financial results, strengthening our foundation and providing the potential for continued expansion of our portfolio, positioning us to serve many more people living with rare diseases in the future.

net product sales graph
net income graph
earnings graph
cash equivalents graph

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL RESULTS 

IN MILLIONS EXCEPT
PER SHARE AMOUNTS

financial highlights table